Navigation Links
HeartSine Technologies Honored With Belfast Ambassador Award at Belfast Business Top 50 Event
Date:10/11/2010

STORMONT, BELFAST, Northern Ireland, Oct. 11 /PRNewswire/ -- HeartSine Technologies, Inc. was honored with the Belfast Ambassador Award at the sixth annual Belfast Business Top 50 event in Stormont, Belfast. The award was presented to the company by the Belfast Media Group for pioneering business in developing areas of Belfast, Ireland.

HeartSine CEO Greg Cash, who accepted the award at the Long Gallery in Stormont on behalf of HeartSine, said, "We are honored to be singled out for the Belfast Ambassador Award.  HeartSine has a rich history of innovation and public awareness, especially in the area of Sudden Cardiac Arrest (SCA). We are proud of the work we've done in Northern Ireland, and all around the world."

Cash took the opportunity to share information about SCA and encouraged the attendees to consider starting a Public Access Defibrillator program in their respective organizations. SCA does not discriminate. It can happen anywhere, to anyone, at any time and accounts for an estimated 425,000 deaths in the United States each year, more than the total death rate for breast cancer, lung cancer, and HIV/AIDS combined. The annual mortality rate from SCA throughout Europe and North America exceeds one million. When a defibrillator is used within the first three to five minutes after the onset of SCA, the victim's chance of survival improves 40 to 75 percent.

The 50 companies recognized at the ceremony represented a diverse range of business leaders and entrepreneurs from the Belfast area. Each has worked tirelessly in their individual fields to progress and develop their businesses, despite the economic challenges.

HeartSine's European headquarters is located at 203 Airport Road West, Belfast, Northern Ireland BT3 9ED. For more information, contact +44 (0) 28 9093 9400, info@heartsine.co.uk.

About HeartSine Technologies (www.heartsine.com)

A world leader in personal and public access defibrillators, HeartSine's mission is to advance the deployment of lifesaving defibrillation therapy in non-traditional areas of care through the development of proprietary technologies and quality products. Its HeartSine® samaritan® PAD Public Access Defibrillator is especially designed for rescuers of all skill levels to administer lifesaving treatment for Sudden Cardiac Arrest. Sophisticated and lightweight, it's ideal for sports facilities, schools, churches and businesses. Additional information:  info@heartsine.com; (866) 478-7463, ext. 112.


'/>"/>
SOURCE HeartSine Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. HeartSine Technologies Recognized as an Index 30 Company at New York-New Belfast Conference
2. HeartSine Technologies Supports Living for Zachary Benefit Golf Tournament
3. HeartSine Technologies Supports Run For Sarah Benefit Event
4. Motorcyclist Volunteers Come to the Rescue With HeartSine AEDs
5. HeartSine and Your Safety Company to Donate a Portion of Sales Proceeds to Sudden Cardiac Arrest Foundation
6. Industry Leader BioStorage Technologies Broadens Sample Management Operations to Include Laboratory Sample Preparation Services
7. DiFUSION Technologies Completes Successful Antimicrobial Implant Animal Trial
8. IDEV Technologies Completes $46 Million Preferred Stock Financing With Piper Jaffray and Additional Strategic Investor
9. DiFUSION Technologies Adds Accomplished Senior Management Team
10. DiFUSION Technologies Receives 510(k) Clearance of Xiphos™ Interbody Implants for Spinal Fusion
11. medSage Technologies Introduces Revolutionary Universal CPAP Monitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... 23, 2017  Directors from Pharma To Market Pty Ltd and ... forces, resulting in the founding of Pharma To Market Pte Ltd, ... Market are pleased to announce their expansion into Asia ... Singapore . The company are delighted to appoint Joelle ... Singapore based entity. Joelle brings with her ...
(Date:2/24/2017)... 24, 2017  Xynomic Pharmaceuticals, Inc., an oncology drug ... has acquired exclusive worldwide rights to develop, manufacture ... inhibitor targeting hematological and solid tumors. ... and 2 clinical trials of Abexinostat in US, ... already been completed, demonstrating that Abexinostat is clinically ...
(Date:2/23/2017)... Südkorea, 23. Februar 2017 LG Innotek hat ... vorgestellt. Die Sterilisationsleistung beträgt das 1,5-fache des 45-mW-Moduls der ... im Bereich zwischen 200 und 280 nm und eignet sich ... indem es ihre DNA zerstört. Das Produkt von LG ... ...
Breaking Medicine Technology:
(Date:2/26/2017)... ... February 26, 2017 , ... ... technology standard in staffing, scheduling, and reporting for healthcare organizations. This comprehensive ... throughout the entire staffing process. StaffBridge technology improves staffing efficiency, maximizes resource ...
(Date:2/24/2017)... MN (PRWEB) , ... February 24, 2017 , ... ... of its newly designed TaskMate Go. Core benefits and advantages built into the ... and a stylish, functional look and feel. Ability to gain the benefits embedded ...
(Date:2/24/2017)... ... February 24, 2017 , ... Dr. Ronald ... officially announced the appointment of Peter A. Bell, DO, MBA, HPF, FACOEP-dist., FACEP, ... (LUCOM), beginning April 10. Dr. Bell comes to Liberty from the Ohio University ...
(Date:2/24/2017)... ... February 24, 2017 , ... The narrative in “ Signal 8: ... ’s true account of his paramedic experiences. Schanssema describes the tragedies he saw, as ... attempts to overcome them. , Schanssema, initially unsure of the career path he wanted ...
(Date:2/24/2017)... ... February 24, 2017 , ... Indiana Fiber Network (IFN) President ... later this year. Dyer started as the Chairman of the Management Committee when ... of the corporation including the recruitment of investor/owners and development of the business plan. ...
Breaking Medicine News(10 mins):